Syngen Biotech Co.,Ltd. (TPEX: 8279)

Syngen Biotech Co.,Ltd. Revenue

Syngen Biotech Co.,Ltd. had revenue of 555.56M TWD in the quarter ending September 30, 2024, with 17.87% growth. This brings the company's revenue in the last twelve months to 2.00B, up 5.82% year-over-year. In the year 2023, Syngen Biotech Co.,Ltd. had annual revenue of 1.84B, down -4.84%.

• Revenue (ttm): 2.00B
• Revenue Growth: +5.82%
• P/S Ratio: 1.77
• Revenue / Employee: 8.10M
• Employees: 247
• Market Cap: 3.55B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.84B	-93.41M	-4.84%
Dec 31, 2022	1.93B	459.33M	31.22%
Dec 31, 2021	1.47B	159.83M	12.19%
Dec 31, 2020	1.31B	14.17M	1.09%
Dec 31, 2019	1.30B	216.82M	20.07%